| 摘要 |
<p>The present invention provides a method for detecting and judging lipid metabolism disorders and a risk of developing diseases caused thereby, and reagents, such as a probe and primer, for lipid metabolism disorder diagnosis, and a reagent kit comprising at least one of such reagents, all of which can be effectively used in the detection method. The present invention can be accomplished by detecting a genetic polymorphism that causes a change (TRA) of the 94th amino acid of FABP1 (fatty acid binding protein 1, liver [Homo sapience]) in a subject.</p> |
